KAZANCHYAN ANNA 4
4 · Foamix Pharmaceuticals Ltd. · Filed May 10, 2018
Insider Transaction Report
Form 4
KAZANCHYAN ANNA
Director
Transactions
- Award
Ordinary Shares
2018-05-08+14,829→ 27,760 total
Footnotes (3)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The ordinary shares underlying this restricted share unit award vest over a period of three years from May 8, 2018 (33.3% on each anniversary of such date) and ending May 8, 2021.
- [F3]The issuer's method of reporting restricted share units has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, this amount includes (i) 12,931 ordinary shares subject to unvested restricted share units that were previously reported in Table II of the reporting person's Form 3 as a derivative security and ii) the 14,829 ordinary shares sub-ject to unvested restricted share units granted on May 8, 2018 and first reported on this Form 4.